Vida Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 15-11-2024
- Paid Up Capital ₹ 3.00 M
as on 15-11-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 14.88%
(FY 2023)
- Profit -146.98%
(FY 2023)
- Ebitda -172.09%
(FY 2023)
- Net Worth -787.58%
(FY 2023)
- Total Assets -20.92%
(FY 2023)
About Vida Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Onkar Yadav, Dhananjay Sawant, and Sanjay Khandagle serve as directors at the Company.
- CIN/LLPIN
U52399PN2011PTC140883
- Company No.
140883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vida Lifesciences Private Limited offer?
Vida Lifesciences Private Limited offers a wide range of products and services, including Metal Furniture Suppliers, Metal Rack, Repair & Maintenance Services, Plant Maintenance Services, Doors and Windows, Commercial Door, Hospital & Medical Lights, Surgical Light, Laboratory Autoclave & Sterilizers, ETO Sterilizer.
Who are the key members and board of directors at Vida Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Onkar Yadav  | Director | 26-Sep-2011 | Current |
| Dhananjay Sawant | Director | 15-Oct-2013 | Current |
| Sanjay Khandagle | Director | 06-Jan-2020 | Current |
Financial Performance of Vida Lifesciences.
Vida Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.88% increase. The company also saw a substantial fall in profitability, with a 146.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 787.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vida Lifesciences?
In 2023, Vida Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vida Lifesciences?
Unlock and access historical data on people associated with Vida Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vida Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vida Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
